INTRODUCTION
Simvastatin is 2, 2 -dimethyl butanoic acid (1S, 3R, 7S, 8S, 8aR) -1, 2, 3, 7, 8, 8a-hexahydro-3, 7-d imethyl-8-[2-[(2R,4R) tetrahydro -4-hydro xy l-6 -o xo -2H pyran-2-yl]ethyl-1-naphthalenyl ester 1, 2 belongs to the group of cholesterol-lowering lactones known as statins which, in 2007, were identified as being the most widely p rescribed drugs in the world. Statins lower cholesterol by inhibit ing the synthesis of mevalonic acid, wh ich is a key precusor in cholesterol synthesis. SMT, a lipid lowering agent that is derived synthetically fro m a fermentation product of Aspergillus terreus has been found to lessen both normal and elevated LDL-C concentrations. The drug is officially listed in 2004 Un ited States Pharmacopocia and the official method of its determination is UV-spectrophotometry [3] [4] [5] , and various other methods are HPTLC 6 , miscellar eletrokinetic chromatography and voltammetry 7 have been reported for the assay of SMT in pharmaceuticals . The method development bottleneck result from the requirement to generate a quantitative and qualitative profile of impurities, enabling the reporting of the identity of each chemical moiety 8 . Two official methods utilising HPLC GRA DIENT methodology are reported in European Pharmacopoeia (EP) and United State Pharmacopoeia (USP) 9, 10 .
MATERIALS AND METHODS
All the reagents used were of HPLC grade and analytical grade and were purchased from Merck Chemicals, India. Reference standard of Simvastatin was supplied as gift sample fro m Sun Pharmaceutical Laboratories Limited, Mumbai with purity of 99.987%.
Preparation of buffer solution:
Mix 5mL of glacial acid in 1000mL of milli Q water. To 1000mL of 5mL g lacial acetic acid solution, add 0.94g m of 1-Hexane sulphonic acid anhydrous.sonicate to dissolve.
Preparation of Mobile phase:
The mobile phase is prepared by mixing buffer: methanol in the ratio of 96:4 Filtered and degas it Chromatographic Run: Load the standard solution of simvastatin in the injector, enter the HPLC parameters as per (Table: 1), save the method, inject and run for 20min. Standard preparation of simvastatin Accurately weigh and transfer about 20 mg of drug simvastatin working standard into 100mL volu metric flask, and about 70 mL of diluents, sonicate to dissolve, dilute to volume with diluents and mix. 
ABS TRACT
A simple, accurate rapid and precise RP-HPLC method has been developed and validated for determ ination of simvastatin in bulk drug. The RP-HPLC separation was achieved on Promosil C-18, (250 mm, 4.6 mm, 5µm) using mobile phase buffer: methanol ph 6.8 (96: 4 v/v) at flow rate of 1.0 ml/min at ambient temperature. The retention times were 9.546 min. for simvastatin. Calibration plots were linear over the concentration range 1-50µg/ml. Quantification was achieved with photodiode array detection at 254 nm over the concentration range of 1-50 µg/ml. The method was validated statistically and applied successfully for the determination of simvastatin. Validation studies revealed that method is specific, rapid, reliable, and reproducible. The high recovery and low relative standard deviation confirm the suitability of the method for the routine determination of simvastatin in bulk drug. 
MET HOD VALIDATION
The developed method was validated according to ICH guidelines. Standard calibration curve were prepared in the mobile phase with 5 concentration ranging from 1-50 µg/ml for simvastatin is injected in to HPLC system keeping the inject ion volume constant. The peak area was plotted against the corresponding concentration to obtain the calibration graphs. To study the reliability and suitability of developed method, recovery experiments were carried out at three levels 80, 100 and 120%. Known concentration of Commercial tablet is spiked with known amounts of simvastatin. At each level of the amount six determinations were performed and the results obtained were co mpared with expected results. Recovery for pharmaceutical fo rmulat ions should be within the range 100±5%. The percent R.S.D of individual measurements was also determined. Precision of the assay was determined by repeatability (intra-day) and intermediate precision (inter-day) for 3 consecutive days. Three different concentration of simvastatin were analysed in six independent series in the same day (intra-day precision) and 3 consecutive days (inter-day precision). The repeatability of sample application and measurement of peak area for act ive co mpounds were exp ressed in terms of percent RSD.
All chro matograms were examined to determine if compounds of interest co-eluted with each other or with any additional excipient peaks. Marketed formu lation were analysed to determine the specificity of the optimized method in the presence of common tablet excipients . Limi of detection (LOD) and limit of quantitation (LOQ) were estimated fro m single to noise ratio. LOD and LOQ were calculated using 3.3 /s and 10 /s formu lae, respectively. Where the standard deviation of the peak areas and s is is the slope of the corresponding calibration curve. To evaluate robustness of HPLC method a few parameters included variation of flow rate, percentage of buffer in the mobile phase, and pH of mob ile phase.
RES ULT AND DISCUSSION
The retention time of simvastatin was peak eluted at 9.546 min. The peaks are well separated with a resolution of 3.344 and Tailing 1.136. The mobile phase comprises of Methanol: Buffer (96:4) v/v at the pH 4.0 was selected as optimized mobile phase, because of the high purity, symmet ry, proper tailing, h igh area and low RT value at same concentration as compared to other trail mob ile phase. Furthermo re, the stability of the drug in the mobile phase were also studied and result indicating that the drug Simvastatin was found to be stable during the storage time of 48 hr ( Table 2) . Linearity of the method was investigated by serially diluting the working standard to give a concentration range of 1-10 µm/ ml and 20 µl fro m this was injected. The flow rate was maintained at 1 ml/ min. temperature of colu mn was kept ambient and the effluent was monitored at 254 nm. Calibrat ion curve was constructed by plotting concentration against peak area ( fig.3 ). 
Fi gure 3: Standard Curve of Simvastatin
The method was validated for linearity, precision, accuracy, specificity, . The system suitability tests for HPLC were carried out on freshly prepared solution of Simvastatin (10 µg/ ml) and parameters were studied. The results were summarized in Table 3 . Resolution 3.344±0.628 Assay of tablets of Simvastatin were perfo med. Twenty tablets of each company of strength 5 mg, 10 mg and 20 mg were weighed and ground to a fine powder. A quantity of tablet powder equivalent to 10 mg of Simvastatin was transferred to 10 ml volu met ric flask, d issolved and diluted with acetonitrile and water mixture to obtain 1 mg/ml. The solution was sonicated for 15 minute and filtered through 0.45 µm membrane filter. The solution was further diluted to obtain concentration 10 µm/ ml. Peak area of the above prepared tablet solutions of Simvastatin were measured by using above mentioned chromatographic conditions and the amount of Simvastatin were found from regression equation (Table 4 ) &Recovery study (Table 5 ). The linear regression date showed a good linear relationship over the concentration range of 1-50 µg/ ml as summarized in Tab le 6. The limit of detection (LOD) and the limit of quantification(LOQ) of the drug were found by scanning the solution of Simvastatin having different lo wer concentrations and the LOD and LOQ were found to be 0.5 and 1 µg/ ml indicates that method is sensitive (Table  6 ). The intraday and interday precision were determined by analyzing standard solution of Simvastatin at three different concentration levels (6, 8, 10 µg/ ml). The % RSD for intraday and interday precision was found to be 0.257 -0.712% and 0.480-1.080% respectively which indicate that method is precise (Tab le 6). Repeatability of the method was studied by injecting 10 µg/ml solution of Simvastatin for six times and peak area was measured and % RSD was calculated which was found to be 0.195 shows repeatability of the method (Table   6 ). Accuracy of the method was evaluated by standard addition method in which appropriate port ion of stock solutions of Simvastatin were spiked into blank placebo matrix to produce concentrations of 80 100 and 120% of theoretical concentration. The mean recovery of spiked samples obtained was in range of 99.16 to 101.24 reveals no interference of excip ients and shows that method is accurate (Table 6 ).
The proposed validated method was successfully applied to determine Simvastatin in tablet form. The results obtained for tablets of Simvastatin were comparable with the corresponding labeled amounts (0.5 mg/tab) (table 4) . Robustness of the method was estimated by changing the mobile phase composition (3±3), wavelength ±1 n m, injection volume (20±2µl), colu mn temperature (40±3 0 ) and RSD values for all these changes calculated were less than 2 indicate that proposed method is robust. The proposed RP-HPLC method was accurate, precise, sensitive and rapid. The method also can be extended for the routine analysis of Simvastatin in tablet dosage form.
CONCLUS ION
It is thus concluded that the proposed method is new, simp le, cost effective, accurate, safe, free from pollution and precise and can be successfully employed in the routine analysis of these drugs in pharmaceutical dosage forms. The proposed method shall prove equally effective to analyze Simvastatin in the corresponding drug sample and may prove to be of great importance in pharmaceutical analysis.
